View Press Releases
-
Certara Simcyp® Simulator Results Replace Ten Human Trials for Chronic Myeloid Leukemia (CML) Therapy asciminib
Biosimulation results highlight how model-informed approaches for drug development and regulatory decision-making save time and money.
Mar 4, 2026
-
Thermo Fisher Scientific Opens Bay Area Cryo-EM Drug Discovery Center to Accelerate Breakthrough Therapies
Thermo Fisher Scientific, the world leader in serving science, today announced the opening of its Cryo-Electron Microscopy (cryo-EM) Drug Discovery Center (CDDC) in South San Francisco. The new center provides pharmaceutical and biotechnology innovators with immersive, hands-on access to advanced cryo-EM technologies designed to accelerate structural insights and the development of life-saving therapies.
Mar 4, 2026
-
Wisdom Bioscience Establishes Scientific Advisory Board to Advance Oral Cancer Diagnostics and Screening
• Drs Giulia Kennedy, Arnold Levine, John Sninsky, Martin Goldberg and Prof Tin Tin Su join SAB • Follows close of initial funding round with investment from Stephen Quake and Jay Flatley
Mar 2, 2026
-
Camgenium Expands NHS Access to Advanced, Risk-Adjusted Clinical Audit Analytics
Mar 2, 2026
-
Ardena Appoints Paul Edwards as Chief People Officer
Mar 2, 2026
-
Proscia Earns Top Performance Score in the US, Sweeping 2026 KLAS Digital Pathology Ratings
Following Proscia’s Global Best in KLAS win in Europe, Concentriq is now the highest-rated digital pathology platform across multiple regions
Mar 1, 2026
-
START Appoints Dr. Frank Smith President of its XenoSTART Preclinical Research Business Unit
Dr. Smith will strengthen XenoSTART’s position as a premier drug development partner, translating PDX-driven insights into faster, more confident oncology development decisions.
Feb 23, 2026
-
Quotient Sciences Extends Commercial Manufacturing Partnership for Ultra-Rare Disease Treatment
Feb 25, 2026
-
Symbiosis Appoints Joanne Anderson as Chief Commercial Officer
Mar 1, 2026
-
Epigenica AB Launches EpiFinder™ cNUC: The First Platform to Simultaneously Profile Multiple Histone Marks and DNA Methylation Directly from Circulating Nucleosomes in Plasma and Serum
Epigenica has announced the launch of EpiFinder™ cNUC, a unique product for liquid biopsies that significantly expands the capabilities of epigenomic research by delivering deep insights directly from circulating nucleosomes.
Feb 24, 2026
-
ELRIG Appoints Dr Kelly Gray and Dr Elaine Duncan to its Board
• Strengthens leadership team to support next phase of growth as organisation evolves to meet needs of global drug discovery community • Drs Gray and Duncan to lead scientific programmes and early career initiatives, respectively
Feb 24, 2026
-
Healthcare Access Performance Leader BlockIt Rebrands as Alluvium Healthcare
Feb 23, 2026
-
Inceptua Group Appoints Healthcare Industry Leader Kurt Hilzinger as Chairman of the Board
Inceptua Group announces the appointment of Kurt J. Hilzinger as Chairman of the Board.
Feb 23, 2026
-
Volta Labs and Watchmaker Genomics Partner to Introduce Callisto™ Complete Kit for DNA EF Library Prep at AGBT 2026
Feb 22, 2026
-
ClearNote Health’s Enhanced Avantect® Pancreatic Cancer Test Delivers Industry-Leading Early Detection Performance
ClearNote Health announced an enhanced Avantect® Pancreatic Cancer Test, which delivers a higher overall cancer detection sensitivity of 82.6% and specificity of 97.5% for patients at elevated risk of this disease.
Feb 22, 2026
-
Integrated DNA Technologies Unveils NGS Innovation Roadmap to Accelerate the Future of Cancer Research
IDT’s NGS roadmap reflects a multi-omics strategy built on differentiated chemistries and algorithms that support DNA, methylation, and RNA sequencing workflows.
Feb 22, 2026
-
Watchmaker Genomics Licenses CRISPR-Cas9 Intellectual Property from Caribou Biosciences to Increase Throughput and Reduce Sequencing Cost per Sample
Feb 16, 2026
-
NSA Labs Helps Leading Biopharmaceutical Companies Get Study Results Faster on Proscia’s Platform
Specialized CRO has delivered 750 neuroscience studies advancing drug R&D with digital pathology
Feb 16, 2026
-
Ambience Healthcare Expands “Chart Awareness” Across Its Intelligence Platform
Feb 11, 2026
-
Carterra Launches Industry’s First 48-channel HT-SPR Platform for Advanced Label-free Biomolecular Screening and Characterization
Feb 8, 2026


